Endomicroscopy, IBS and Food Intolerance
Confocal Endomicrosopy for the Detection of Food Intolerance in Patients With Irritable Bowel Syndrome
1 other identifier
observational
60
1 country
1
Brief Summary
Background: The immediate endoscopic identification and diagnosis of intraepithelial structures and immediate and delayed reactions to allergens in the mucosal surface of the gut are unmet goals in the diagnosis and management of subjects with food intolerances, who are negative to all available tests. Endomicroscopy may be helpful to further visualize and characterize unmasked small bowel reactions to foods, which has not been described before. Confocal laser endomicroscopy provides confocal microscopic imaging simultaneously to the macroscopic view ,which enables the examiner to see immediate reactions after exposure and it further allows capturing of fluid excreted by the gut for further analysis to understand the pathology behind this reaction further. N=50 patients with unexplained bloating and diarrhoea with suspicion of food intolerance and negative testing with routine methods. Patients with Lactose intolerance n=10 patients to compare results. Patients with Fructose intolerance n=10 patients to compare results. Volunteers with Barrett's esophagus who need evaluation for possible dysplasia in the Barrett's mucosa with confocal endomicrosopy but no symptoms of bloating and abdominal pain (n=10) to serve as healthy controls for allergy testing. Methods: The primary objective is to investigate whether endomicroscopy will allow the detection of an allergic reaction of the gut after exposure of the 5 major allergens in the following way: After standard gastroscopy with the endomicroscope including evaluation of the surface of the upper gastrointestinal tract, i.v. injection of Fluorescein, then initial visualisation of the duodenal surface including count of initial lymphocytes/mononuclear cells in the lamina propria: Allergen 1 (milk), allergen 2 (wheat), allergen 3 (soya),allergen 4 (apple), allergen 5 (yeast). The primary endpoint is the visible marked increase of lymphocytes and mononuclear cells in the lamina propria of the duodenum, representing an acute reaction to one of the allergens sprayed to its surface through the endoscope channel.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 20, 2012
CompletedFirst Posted
Study publicly available on registry
September 25, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedJune 3, 2015
June 1, 2015
2 years
September 20, 2012
June 2, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Number of mucosal reaction
immediate
Eligibility Criteria
* N=50 patients with unexplained bloating and diarrhoea with suspicion of food intolerance and negative testing with routine methods * N=10 patients with Lactose intolerance * N=10 patients with Fructose intolerance * N=10 volunteers with Barrett's esophagus who need evaluation for possible dysplasia in the Barrett's mucosa with confocal endomicrosopy but no symptoms of bloating and abdominal pain (n=10) to serve as healthy controls for allergy testing
You may qualify if:
- age \> 18 years
- ongoing abdominal symptoms such as bloating and abdominal pain
- negative routine testing for food intolerance (or known lactose/fructose intolerance)
- written informed consent
You may not qualify if:
- no consent
- known reason for the abdominal pain and bloating other than lactose/fructose intolerance
- M. Whipple
- known infectious gastrointestinal disease
- stricture in the upper gastrointestinal tract
- age \>18years
- impaired renal function (Creatinine \>1.2 mg/dL)
- pregnancy or breast feeding
- inability to obtain informed consent
- active GI Bleeding
- known allergy to Methylene blue or Fluorescein
- participation in other clinical trials within the last 4 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Schleswig Holstein, Campus Kiel, Unit Experimental Endoscopy
Kiel, 24105, Germany
Related Publications (1)
Fritscher-Ravens A, Schuppan D, Ellrichmann M, Schoch S, Rocken C, Brasch J, Bethge J, Bottner M, Klose J, Milla PJ. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2014 Nov;147(5):1012-20.e4. doi: 10.1053/j.gastro.2014.07.046. Epub 2014 Jul 30.
PMID: 25083606DERIVED
Biospecimen
* duodenal biopsies * duodenal fluid
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Annette Fritscher-Ravens, Prof. Dr.
University Schleswig-Holstein
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
September 20, 2012
First Posted
September 25, 2012
Study Start
September 1, 2012
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
June 3, 2015
Record last verified: 2015-06